SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    New CURE Act Would Prevent Cannabis Use Being Grounds For Dismissal for Federal Employees

    By

    New legislation introduced in the US last week seeks to ease federal restrictions on employees who are past or current cannabis users.

    The Cannabis Users Restoration of Eligibility (CURE) Act, introduced by two bipartisan lawmakers, would prevent any past or ongoing cannabis consumption from being used as a reason for employees to be found unsuitable for federal employment or a security clearance.

    If passed, it would also be applied retroactively, enabling those who have previously been dismissed on these grounds to appeal.

    Democratic Senator Jamie Raskin, who introduced the bill alongside Republican Representative Nancy Mace, said: “I am proud to partner with my friend Representative Mace to introduce the bipartisan CURE Act that will eliminate the draconian, failed and obsolete marijuana policies that prevent talented individuals from becoming honourable public servants in their own government.”

    READ MORE: Adult Use Cannabis Sales Begin in Minnesota

    High Times reported that the CURE act has also garnered support from a number of justice reform advocates and cannabis industry groups, including Law Enforcement Action Partnership (LEAP), NORML and the US Cannabis Council.

    “Millions of patriotic, conscientious Americans use cannabis legally each year, but they are consistently penalised by outdated federal regulations,” said Ed Conklin, executive director of the U.S. Cannabis Council. “We strongly support the CURE Act because it will bring federal employment policies into line with the views of most Americans. Cannabis use should never prevent a qualified candidate from serving his or her country as a federal employee.”

    Ben Stevens

    Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free